YUNNAN BAIYAO GROUP CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.26 CNY | +2.81% |
|
-2.04% | +14.47% |
| May. 13 | Yunnan Baiyao's Unit to Conduct Clinical Trials on Prostate Cancer Drug | MT |
| May. 13 | Yunnan Baiyao to Conduct Clinical Trials on Flurbiprofen Gel Patch | MT |
Evolution of the average Target Price on Yunnan Baiyao Group Co.,Ltd
Price target over the last 5 years
History of analyst recommendation changes
2ec.4p00qsOocY2CtSdKKHX5o_QbArkNpfCRy5NjPESo8GE.qdF5-qX9HMfphV45GjnK0bBfNJR51pzHmP4PZH3Otyuj62TB-v4C3u_qEw~b2e1189b9a916cc4a74234942fd6d90e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
56.26
CNY
Average target price
64.08
CNY
Spread / Average Target
+13.90%
High Price Target
69.4
CNY
Spread / Highest target
+23.36%
Low Price Target
54.2
CNY
Spread / Lowest Target
-3.66%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- 000538 Stock
- Consensus Yunnan Baiyao Group Co.,Ltd